跳至主要内容
临床试验/JPRN-UMIN000003033
JPRN-UMIN000003033已完成未知

Global Assessment Study of Anti-cholinergics on Efficacy and Tolerability for Patients with OAB - GAP Study

GAP Study Group0 个研究点目标入组 300 人开始时间: 2010年4月14日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Genuine stress incontinence. (2)Prostate cancer, bladder cancer, urinary tract stones, symptomatic urinary tract infection, recurrent urinary tract infection and interstitial cystitis. (3)Indwelling or intermittent urethral catheterization. (4)Polyuria. (5)Lower urinary tract symptom is unstable. (6)Serious heart failure, serious liver failure and serious kidney failure. (7)Contraindications to antimusucarinic agents. (8)Sjogren's syndrome or hyposalivation by RT. (9)Treatment with banned medicine within 2 weeks before the run-in period. (10)Electric stimulation therapy or bladder training within 3 months before the run-in period. (11)Genitourinary surgery within 6 months before the run-in period. (12)Any other cases who are regarded as inadequate for study enrollment by the investigator.

研究者

发起方
GAP Study Group

相似试验